These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12144950)

  • 21. Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels.
    Schlösser R; Gründer G; Anghelescu I; Hillert A; Ewald-Gründer S; Hiemke C; Benkert O
    Neuropsychobiology; 2002; 46(1):33-40. PubMed ID: 12207145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (S)-amisulpride as a discriminative stimulus in C57BL/6 mice and its comparison to the stimulus effects of typical and atypical antipsychotics.
    Donahue TJ; Hillhouse TM; Webster KA; Young R; De Oliveira EO; Porter JH
    Eur J Pharmacol; 2014 Jul; 734():15-22. PubMed ID: 24726559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons.
    Di Giovanni G; Di Mascio M; Di Matteo V; Esposito E
    J Pharmacol Exp Ther; 1998 Oct; 287(1):51-7. PubMed ID: 9765321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
    Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
    Svestka J; Synek O; Tomanová J; Rodáková I; Cejpková A
    Neuro Endocrinol Lett; 2007 Dec; 28(6):881-8. PubMed ID: 18063941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats.
    Kapur S; Langlois X; Vinken P; Megens AA; De Coster R; Andrews JS
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1129-34. PubMed ID: 12183672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
    Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU
    Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
    Chen CK; Huang YS; Ree SC; Hsiao CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A possible effect of amisulpride on a prolactinoma growth in a woman with borderline personality disorder.
    Perroud N; Huguelet P
    Pharmacol Res; 2004 Sep; 50(3):377-9. PubMed ID: 15225684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
    Fric M; Laux G
    Psychiatr Prax; 2003 May; 30 Suppl 2():S97-101. PubMed ID: 14509051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of amisulpride, an atypical antipsychotic which blocks preferentially presynaptic dopamine autoreceptors, on integrated functional cerebral activity in the rat.
    Cudennec A; Fage D; Bénavidès J; Scatton B
    Brain Res; 1997 Sep; 768(1-2):257-65. PubMed ID: 9369323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats: an experimental model of estrogen-dependent hyperprolactinemia.
    Ribeiro MF; Spritzer PM; Barbosa-Coutinho LM; Oliveira MC; Pavanato MA; Silva IS; Reis FM
    Braz J Med Biol Res; 1997 Jan; 30(1):113-7. PubMed ID: 9222412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses.
    Glatard A; Guidi M; Delacrétaz A; Dubath C; Grosu C; Laaboub N; von Gunten A; Conus P; Csajka C; Eap CB
    Clin Pharmacokinet; 2020 Mar; 59(3):371-382. PubMed ID: 31552612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin and calcium metabolism: influence of hyperprolactinemia on immunoreactive parathyroid hormone levels in man and in the rat.
    Fiore CE; D'Agata R; Clementi G; Malatino LS
    J Endocrinol Invest; 1984 Dec; 7(6):647-52. PubMed ID: 6442311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible oncostatic action of cysteamine on the pituitary glands of oestrogen-primed hyperprolactinaemic rats.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Oct; 127(1):119-27. PubMed ID: 2103572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the regulatory effect of Peony-Glycyrrhiza Decoction on prolactin hyperactivity and underlying mechanism in hyperprolactinemia rat model.
    Wang D; Wang W; Zhou Y; Wang J; Jia D; Wong HK; Zhang ZJ
    Neurosci Lett; 2015 Oct; 606():60-5. PubMed ID: 26297122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.
    Cookson J; Hodgson R; Wildgust HJ
    J Psychopharmacol; 2012 May; 26(5 Suppl):42-51. PubMed ID: 22472310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality.
    Möller HJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1101-11. PubMed ID: 14642970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.